Tag Archives: Daiichi’s

AstraZeneca, Daiichi’s breast cancer drug gets accelerated approval from FDA

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid (This Dec.20 story corrects first paragraph to say the approval came four months ahead of schedule, not three months, after FDA clarification) (Reuters) – The U.S.… Read More »